Impact of Fish Oil Supplementation in 3rd Trimester of Pregnancy on Maternal and Offspring Health
NCT01353807 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 533
Last updated 2014-02-28
Summary
The aim of the trial is to investigate the effect of daily supplementation with 2.7 grams of long chain n-3 fatty acids during the third trimester of pregnancy. In 1990, 533 pregnant women, while they were in gestational week 30, were randomized to fish oil supplements providing the mentioned amount of long chain n-3 fatty acids, olive oil supplements, or no supplements; they were asked to take the supplements until delivery. Health outcomes were assessed during pregnancy and delivery. Further, offspring health and development has been examined during the ensuring two decades by making linkages to the rich Danish health and administrative registries, by asking the offspring to complete web-based questionnaires, and by examining the offspring physically.
Conditions
- Preterm Delivery
- Atopy
- Metabolic Syndrome
Interventions
- DIETARY_SUPPLEMENT
-
Fish oil
4 1-g gelatine capsules per day providing 2,7 grams long chain n-3 fatty acids
- DIETARY_SUPPLEMENT
-
Olive oil
4 1-g gelatine capsules with virgin olive oil
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH -
The Danish Council for Strategic Research
collaborator OTHER -
Danish Council for Independent Research
collaborator OTHER -
Lundbech Foundation
collaborator UNKNOWN -
EU Commision, DG12
collaborator UNKNOWN -
Centre for Fetal Programming, Denmark
lead OTHER
Principal Investigators
-
Sjurdur F. Olsen, MD · Statens Serum Institut
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1989-11-30
- Primary Completion
- 1990-12-31
- Completion
- 2011-05-31
Countries
- Denmark
Study Locations
More Related Trials
-
Fish Oil and Folate Supplementation During Pregnancy
NCT01180933 ·Status: COMPLETED ·Phase: NA
-
Does Fish Oil Prevent Depression in Pregnancy and Postpartum?
NCT00711971 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation Disorders
NCT02336243 ·Status: UNKNOWN ·Phase: PHASE3
-
Docosahexaenoic Acid (DHA) Supplementation in High Risk Pregnancies
NCT04069195 ·Status: UNKNOWN ·Phase: NA
-
N-3 Fatty Acid Requirements for Human Development
NCT00620672 ·Status: COMPLETED ·Phase: PHASE1
-
Cytokines, PUFA Tissue Concentrations and Treatment Selection in Antenatal MDD
NCT03101540 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Omega-3 Fatty Acids for Major Depressive Disorder During Pregnancy
NCT00618865 ·Status: COMPLETED ·Phase: NA
-
Effects of Prenatal DHA Supplements on Infant Development
NCT00646360 ·Status: COMPLETED ·Phase: NA
-
Fish Oil Supplementation in Lactation
NCT00266305 ·Status: COMPLETED ·Phase: NA
-
Effects of Docosahexaenoic Acid (DHA) on Fetal Cardiac Outcomes
NCT01007110 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Alpha Linolenic Acid (ALA) Supplementation During Pregnancy
NCT03040856 ·Status: WITHDRAWN ·Phase: NA
-
The Effects of Omega-3 PUFAs on the Infant Microbiome and Immunity
NCT03297801 ·Status: COMPLETED
-
DHA Supplementation and Pregnancy Outcome
NCT02219399 ·Status: COMPLETED ·Phase: NA
-
A Preliminary Study on Effect of Omega-3 on Human Sperm
NCT00479960 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Omega Tots: A Randomized, Controlled Trial of Long-chain Polyunsaturated Fatty Acid Supplementation of Toddler Diets and Developmental Outcomes
NCT01576783 ·Status: COMPLETED ·Phase: PHASE4
-
26 Weeks' Dietary Supplementation With DHA- and EPA-enriched Oils on Sleep Efficiency in Healthy Adults
NCT03559361 ·Status: COMPLETED ·Phase: NA
-
The Efficacy of Omega-3 Fatty Acids in Maintaining Optimal Mental Health in Elderly People
NCT00124852 ·Status: COMPLETED ·Phase: NA
-
Prenatal DHA and Neurofunctional Development
NCT02709239 ·Status: COMPLETED ·Phase: NA
-
Investigations on Improving Docosahexaenoic and Arachidonic Acid Content in Preterm Infant Formula
NCT01300130 ·Status: COMPLETED ·Phase: NA
-
Diet and Physical Activity Counseling and n3-long Chain (PUFA) Supplementation in Obese Pregnant Women
NCT02574767 ·Status: COMPLETED ·Phase: NA
-
The Synchronized Trial on Expectant Mothers With Depressive Symptoms by Omega-3 PUFAs (SYNCHRO)in Tokyo: Open Trial
NCT07013981 ·Status: COMPLETED ·Phase: NA
-
Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma
NCT06560255 ·Status: RECRUITING ·Phase: PHASE3
-
A Randomized Clinical Trial on Supplementation of DHA and AA to Preterm Infants
NCT00226187 ·Status: COMPLETED ·Phase: NA
-
High Dose Omega 3 in People at Risk for Dementia
NCT03926351 ·Status: UNKNOWN ·Phase: PHASE2
-
Supplementation of Alpha-linolenic Acid (ALA)-Rich Oil in Humans
NCT01317290 ·Status: COMPLETED ·Phase: EARLY_PHASE1